Reference | N (eyes) | Group | Blood flow velocity (mm/s) | Blood flow rate (pl/s) | Vessel diameter (μm) | Dbox | D0 |
---|---|---|---|---|---|---|---|
Xu et al. [18] | 20 | 9 am vs. 5 pm | 0.62 ± 0.31 (9 am) 0.63 ± 0.25 (5 pm) | 166.20 ± 85.78 (9 am) 158.03 ± 69.57 (5 pm) | 21.68 ± 2.47 (9 am) 21.05 ± 2.79 (5 pm) | 1.61 ± 0.06 (9 am) 1.64 ± 0.04 (5 pm) (*) | 1.68 ± 0.04 (9 am) 1.70 ± 0.04 (5 pm) (*) |
Jiang et al. [21] | 6 | Baseline vs. 6h after CL wear | 0.60 ± 0.12 (B) 0.88 ± 0.21 (6 h) (*) | 129.8 ± 59.9 (B) 207.2 ± 81.3 (6h) (*) | 18.8 ± 2.7 (B) 19.6 ± 2.4 (6 h) (*) | 1.63 ± 0.05 (B) 1.69 ± 0.03 (6 h) (*) | 1.71 ± 0.03 (B) 1.76 ± 0.03 (6 h) (*) |
Chen et al. [32] | 22 | Baseline vs. 6h after CL wear | 0.51 ± 0.20 (B) 0.65 ± 0.22 (6 h) (*) |  | 17.8 ± 1.8 (B) 17.9 ± 1.2 (6 h) |  |  |
Shi et al. [23] | 60 | HCL vs. NCL | 0.59 ± 0.19 (H) 0.48 ± 0.17 (N) (*) | 119 ± 38 (H) 92 ± 39 (N) (*) | 16.9 ± 1.3 (H) 17.3 ± 1.6 (N) | 1.64 ± 0.05 (H) 1.61 ± 0.05 (N) (*) | 1.71 ± 0.05 (H) 1.69 ± 0.04 (N) (*) |
Hu et al. [33] | 166 | HCL vs. NCL Female vs. Male | 0.61 ± 0.15 (H) 0.50 ± 0.14 (N) (*) 0.51 ± 0.14 (F) 0.42 ± 0.13 (M) (*) | 140 (H) 94.5 (N) (*) 93.7 (F) 80.4 (M) (*) | 18.3 (H) 16.4 (N) (*) 16.2 (F) 16.6 (M) | 1.67 (H) 1.62 (N) (*) 1.61 (F) 1.62(M) | 1.75 (H) 1.69 (N) (*) 1.68 (F) 1.69 (M) |
Deng et al. [22] | 16 | Tarsal conjunctiva (T) vs. Lid wiper (L) vs.Bulbar conjunctiva (B) |  |  |  | 1.731 ± 0.026 1.740 ± 0.030 (T*) 1.411 ± 0.116 1.548 ± 0.079 (L*) 1.587 ± 0.059 1.632 ± 0.060 (B*) |  |
Chen et al. [24] | 56 | Baseline vs. After an air puff | 0.50 ± 0.15 (B) 0.55 ± 0.17 (A) (*) |  | 22.13 ± 1.84 (B) 22.21 ± 2.04 (A) | 1.64 ± 0.04 (B) 1.65 ± 0.04 (A) |  |
Chen et al. [25] | 50 | DED patients vs. Healthy human | 0.59 ± 0.09 (D) 0.47 ± 0.12 (H) (*) | 169.5 ± 1.8 (D) 107.2 ± 49.6 (H) (*) | 21.8 ± 1.8 (D) 17.9 ± 2.2 (H) (*) | 1.65 ± 0.04 (D) 1.60 ± 0.07 (H) (*) |  |